American Journal of Neuroradiology, Vol 16, Issue 1 61-68, Copyright © 1995 by American Society of Neuroradiology
ARTICLES |
Proton MR spectroscopy of the brain in 14 patients with Parkinson disease
BC Bowen, RE Block, J Sanchez-Ramos, PM Pattany, DA Lampman, JB Murdoch and RM Quencer
Department of Radiology, University of Miami School of Medicine, FL.
PURPOSE: To determine whether the proton spectra from patients with clinically diagnosed Parkinson disease differ from the spectra of age- matched healthy subjects with respect to the major cerebral metabolite resonances as well as lactate. METHODS: Fourteen patients with Parkinson disease (38 to 81 years of age) and 13 healthy control subjects (37 to 81 years of age) were studied using image-guided, single-voxel (27-cm3 volume) proton MR spectroscopy of the occipital lobe. RESULTS: The peak area ratios of N-acetyl aspartate to creatine and N-acetyl aspartate to choline for Parkinson patients did not show a statistically significant difference from the corresponding ratios for control subjects. There was a very significant increase in the ratio of lactate to N-acetyl aspartate for patients with Parkinson disease, with the greatest increase (threefold) manifested by the subgroup (n = 4) with dementia. The difference in N-acetyl aspartate to choline between women (n = 7) with Parkinson disease and healthy women (n = 9) approached significance. No dependence of the peak ratios on age, duration of Parkinson disease, or medication (L-dopa) regimen was found. CONCLUSION: Preliminary results indicating an increase in cerebral lactate in patients with Parkinson disease support the hypothesis that Parkinson disease is a systemic disorder characterized by an impairment of oxidative energy metabolism. The larger increases for Parkinson patients with dementia may be diagnostically useful in assessing clinical course and in differentiating Parkinson disease from other causes of dementia. Additional studies are needed, though, to quantitate lactate changes and identify potential contributions from lipid resonances better.
This article has been cited by other articles:
 |
|
 |
|
  X.-m. Zha, R. Wang, D. M. Collier, P. M. Snyder, J. A. Wemmie, and M. J. Welsh Oxidant regulated inter-subunit disulfide bond formation between ASIC1a subunits PNAS, March 3, 2009; 106(9): 3573 - 3578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Tessa, M. Giannelli, R. Della Nave, C. Lucetti, C. Berti, A. Ginestroni, U. Bonuccelli, and M. Mascalchi A Whole-Brain Analysis in De Novo Parkinson Disease AJNR Am. J. Neuroradiol., April 1, 2008; 29(4): 674 - 680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Dormont, D.J. Seidenwurm, and for the Expert Panel on Neurologic Imaging Dementia and Movement Disorders AJNR Am. J. Neuroradiol., January 1, 2008; 29(1): 204 - 206. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Summerfield, B. Gomez-Anson, E. Tolosa, J. M. Mercader, M. J. Marti, P. Pastor, and C. Junque Dementia in Parkinson Disease: A Proton Magnetic Resonance Spectroscopy Study Arch Neurol, September 1, 2002; 59(9): 1415 - 1420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Pattany, R. P. Yezierski, E. G. Widerstrom-Noga, B. C. Bowen, Alberto. Martinez-Arizala, B. R. Garcia, and R. M. Quencer Proton Magnetic Resonance Spectroscopy of the Thalamus in Patients with Chronic Neuropathic Pain after Spinal Cord Injury AJNR Am. J. Neuroradiol., June 1, 2002; 23(6): 901 - 905. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-Y. Hsu, A.-T. Du, N. Schuff, and M. W. Weiner Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy in Dementias J Geriatr Psychiatry Neurol, September 1, 2001; 14(3): 145 - 166. [Abstract] [PDF]
|
|
|
|
|
|
B. C. Bowen, P. M. Pattany, W. G. Bradley, J. B. Murdoch, F. Rotta, A. A. Younis, R. C. Duncan, and R. M. Quencer MR Imaging and Localized Proton Spectroscopy of the Precentral Gyrus in Amyotrophic Lateral Sclerosis AJNR Am. J. Neuroradiol., April 1, 2000; 21(4): 647 - 658. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Hashimoto, M. Tayama, M. Miyazaki, Y. Yoneda, T. Yoshimoto, M. Harada, H. Miyoshi, M. Tanouchi, and Y. Kuroda Differences in Brain Metabolites Between Patients With Autism and Mental Retardation as Detected by in Vivo Localized Proton Magnetic Resonance Spectroscopy J Child Neurol, February 1, 1997; 12(2): 91 - 96. [Abstract] [PDF]
|
|